假阳性利福平耐药Xpert MTB/RIF的处理——作者回复。

{"title":"假阳性利福平耐药Xpert MTB/RIF的处理——作者回复。","authors":"J. S. Ngabonziza, T. Decroo, G. Torrea, Patrick Migambi, A. Van Deun, L. Rigouts, B. D. de Jong","doi":"10.1016/s2666-5247(20)30125-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":344281,"journal":{"name":"The Lancet. Microbe","volume":"81 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of falsepositive rifampicin resistant Xpert MTB/RIF - Authors' reply.\",\"authors\":\"J. S. Ngabonziza, T. Decroo, G. Torrea, Patrick Migambi, A. Van Deun, L. Rigouts, B. D. de Jong\",\"doi\":\"10.1016/s2666-5247(20)30125-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":344281,\"journal\":{\"name\":\"The Lancet. Microbe\",\"volume\":\"81 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet. Microbe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2666-5247(20)30125-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Microbe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2666-5247(20)30125-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}